全球全幻灯片成像市场 – 行业趋势和 2031 年预测

全幻灯片成像市场分析和规模

在病理学和诊断学领域，全玻片成像正在彻底改变疾病（尤其是癌症）的诊断方式。WSI 允许病理学家将整个玻璃片数字化，从而创建可在计算机屏幕上分析的高分辨率图像。这种数字化方法通过实现先进的图像分析技术和人工智能的使用，提高了诊断的准确性和效率。此外，WSI 还促进了远程诊断，使病理学家可以从世界任何地方访问和评估玻片，从而改善获取专家意见的渠道并减少诊断延迟。

2023 年全球全幻灯片成像市场规模价值 10.4 亿美元，预计到 2031 年将达到 33.9 亿美元，2024 年至 2031 年预测期内的复合年增长率为 15.90%。除了对市场价值、增长率、细分、地理覆盖范围和主要参与者等市场情景的见解外，Data Bridge Market Research 策划的市场报告还包括深度专家分析、患者流行病学、管道分析、定价分析和监管框架。

报告范围和市场细分       

Market Definition

Whole slide imaging (WSI) is a process that involves scanning traditional glass microscope slides to create high-resolution digital images of the entire tissue sample. These digital slides can be viewed, analyzed, and shared on computer screens, enabling remote diagnosis, digital archiving, and advanced image analysis. Whole slide imaging is widely used in pathology for educational, clinical, and research purposes.

Whole Slide Imaging Market Dynamics

Drivers

• Growing Supportive Government Policies

Government worldwide are increasingly recognizing the benefits of digital pathology and are implementing policies to promote its adoption. Initiatives include funding for healthcare technology upgrades, grants for research and development in digital pathology, and regulatory frameworks that encourage the use of digital tools in medical diagnostics. These policies aim to improve diagnostic accuracy, reduce healthcare costs, and enhance patient care. By providing financial incentives and regulatory support, governments are facilitating the widespread implementation of whole slide imaging technologies in medical institutions.

• Rising Prevalence of Chronic Diseases

Rising chronic diseases demands for accurate and efficient diagnostic tools that can handle large volumes of tissue samples with high precision. WSI addresses these needs by digitizing entire pathology slides, allowing pathologists to analyze samples more comprehensively and accurately. This technology facilitates earlier detection, precise diagnosis, and personalized treatment planning, crucial in managing chronic diseases effectively. Moreover, WSI supports research efforts aimed at understanding disease mechanisms and developing new therapies, further driving its adoption in healthcare systems worldwide.

Opportunities

• Advancements in Digital Pathology

Advancements in digital pathology include significant improvements in imaging technologies, such as higher resolution scanners and faster image processing capabilities, which enhance the quality and efficiency of slide digitization. Integration of artificial intelligence (AI) and machine learning algorithms further improves diagnostic accuracy by assisting pathologists in analyzing digital slides. Moreover, digital pathology enables seamless integration with electronic health records (EHRs) and laboratory information systems (LIS), streamlining workflow and enhancing data management. These technological advancements boost diagnostic capabilities and support remote consultations, telepathology, and collaborative research efforts, thereby driving the adoption of whole slide imaging across healthcare settings worldwide.

• Growth in Research and Development

Whole slide imaging enables researchers to efficiently analyze large volumes of tissue samples with high-resolution digital images, facilitating more detailed and accurate investigations into diseases and treatments. This capability is crucial in pharmaceutical and biotechnology sectors for drug discovery, efficacy testing, and toxicology studies. Additionally, whole slide imaging supports collaborative research efforts by allowing seamless sharing and remote access to digital slides among researchers globally, enhancing productivity and accelerating scientific discoveries.

Restraints/Challenges

• High Initial Investment

Whole slide imaging systems involve substantial costs for acquiring scanners, digital slide management software, and IT infrastructure capable of handling large image data. These upfront expenses can be prohibitive for smaller healthcare facilities, pathology labs, and research institutions, limiting their ability to adopt WSI technology. Moreover, ongoing maintenance and upgrade costs add to the financial burden.

• Growing Management Challenges

Management challenges include establishing robust storage solutions capable of managing massive image files securely and efficiently. Additionally, integrating WSI systems with existing laboratory information systems (LIS) and electronic health records (EHR) can be technically demanding and costly. Training pathologists and laboratory personnel to effectively use WSI technology and ensuring compliance with data privacy regulations further complicate implementation.

This market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Whole Slide Imaging Market Scope

The market is segmented on the basis of technology, application and end user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Technology

• Scanners
• IT Infrastructure
• Viewer
• Image Management System

Application

• Telepathology
• Cytopathology
• Immunohistochemistry
• Hematopathology

End User

• Hospitals
• Pharmaceutical and Biopharmaceutical Companies
• Laboratories
• Academic Institute
• Research
• Others

Whole Slide Imaging Market Regional Analysis/Insights

The market is analyzed and market size insights and trends are provided by country, technology, application and end user as referenced above.

The countries covered in the market report are U.S., Canada, Mexico, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America.

Asia-Pacific dominates the market due to significant advancements in drug discovery research and growing awareness of the technology's benefits. Increased investment in healthcare infrastructure and the rising prevalence of chronic diseases also drive market growth. Additionally, government initiatives supporting digital pathology further bolster the adoption of whole slide imaging in the region.

North America is expected to experience substantial growth in the market due to increased government initiatives promoting the adoption of advanced technologies. This growth is further fueled by a rise in research and development activities across various industries. The region's emphasis on innovation and technological advancements is expected to drive significant market expansion during this period.

报告的国家部分还提供了影响单个市场因素和国内市场监管变化，这些因素和变化会影响市场的当前和未来趋势。下游和上游价值链分析、技术趋势和波特五力分析、案例研究等数据点是用于预测单个国家市场情景的一些指标。此外，在提供国家数据的预测分析时，还考虑了全球品牌的存在和可用性以及它们因来自本地和国内品牌的大量或稀缺竞争而面临的挑战、国内关税和贸易路线的影响。

医疗保健基础设施增长安装基础和新技术渗透

该市场还为您提供每个国家/地区资本设备医疗支出增长、市场上不同类型产品的安装基数、使用生命线曲线的技术影响以及医疗监管情景的变化及其对市场的影响的详细市场分析。数据适用于 2016-2021 年的历史时期。

竞争格局和全幻灯片成像市场分析

市场竞争格局按竞争对手提供详细信息。详细信息包括公司概况、公司财务状况、产生的收入、市场潜力、研发投资、新市场计划、全球影响力、生产基地和设施、生产能力、公司优势和劣势、产品发布、产品宽度和广度、应用主导地位。以上提供的数据点仅与公司对市场的关注有关。

市场上的一些主要参与者包括：

• 奥林巴斯株式会社（日本）
• Leica Biosystems Nussloch GmbH（德国）
• 滨松光子学株式会社（日本）
• 3DHISTECH 有限公司 (匈牙利)
• Koninklijke Philips NV（荷兰）
• Indica Labs, Inc.（美国）
• Inspirata, Inc.（美国）
• 尼康仪器公司（日本）
• Mikroscan Technologies, Inc.（美国）
• Visiopharm A/S（丹麦）
• PerkinElmer Inc.（美国）
• Akoya Biosciences, Inc.（美国）
• 西门子医疗股份公司（德国）
• Hologic, Inc.（美国）
• 卡尔蔡司公司（德国）

SKU-63612